dNovo
dNovo, based in San Jose, CA, specializes in curing hair loss using proprietary cellular reprogramming technology to create new hair, aiming to differentiate from traditional treatments that focus on maintaining existing hair.
Company Overview
dNovo is a healthcare company based in San Jose, CA, USA. The company was founded in 2018 and has a team of four highly trained professionals. Specializing in cellular reprogramming technology, dNovo aims to cure hair loss by creating new hair, differentiating themselves from other companies that focus on maintaining existing hair. They participated in Y Combinator's Summer 2018 batch and have developed a proprietary technology to convert patient-derived cells into medically relevant cell types.
Services
dNovo specializes in curing hair loss by creating new hair through cellular reprogramming. Their proprietary technology enables the conversion of patient-derived cells into personalized hair stem cells. The company aims to offer therapeutic solutions that go beyond maintaining current hair, instead focusing on generating new, healthy hair. This innovative approach leverages their unique reprogramming technique to address hair loss at its root cause.
Founders
The founding team of dNovo includes PhDs and MDs trained at prestigious institutions such as Stanford, Harvard, and Caltech. This team brought together their expertise in biomedical research and cellular technologies to develop and advance dNovo's innovative approach to treating hair loss through cellular reprogramming.
Research and Development
dNovo has developed and demonstrated their groundbreaking technology by successfully growing hair on mice using reprogrammed hair stem cells. The company has also managed to generate human dermal papilla cells with their proprietary direct reprogramming technology. This research aims to establish a reliable method to produce new hair, with the potential to extend this cellular reprogramming approach to creating other cell types, tissues, or organs on demand.
Y Combinator S18 Participation
dNovo participated in Y Combinator's Summer 2018 batch, leveraging the accelerator's resources and network to refine and scale their innovative technology. Y Combinator's support has been instrumental in dNovo's development, providing exposure and mentorship crucial for a healthcare start-up aiming to disrupt traditional approaches to treating hair loss.